These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35815926)

  • 21. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis.
    Wang J; Sun Z; Wang J; Tian Q; Huang R; Wang H; Wang X; Han F
    Cancer Med; 2021 Sep; 10(18):6515-6533. PubMed ID: 34331382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
    Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
    Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory Effects of SLC7A2-CPB2 on Lymphangiogenesis: A New Approach to Suppress Lymphatic Metastasis in HNSCC.
    Song K; Li Y; Yang K; Lu T; Wang M; Wang Z; Liu C; Yu M; Wang M; Cheng Z; Pan M; Hu G
    Cancer Med; 2024 Oct; 13(19):e70273. PubMed ID: 39382373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Potential of Lipid Droplet-associated Genes as Diagnostic and Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma.
    Bai YT; Wang X; He MJ; Xie JR; Chen XJ; Zhou G
    Comb Chem High Throughput Screen; 2024; 27(1):136-147. PubMed ID: 36998140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of fatty acid desaturase 3 predicts poor prognosis in head and neck squamous cell carcinoma.
    Su K; Wang Y; Gu H; Ma L; Xuan G
    Medicine (Baltimore); 2022 Dec; 101(49):e32119. PubMed ID: 36626435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.
    Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T
    Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474
    [No Abstract]   [Full Text] [Related]  

  • 33. Construction of a nomogram for predicting HNSCC distant metastasis and identification of EIF5A as a hub gene.
    Chen X; Zhang Y; Chen S; Yang Y; Sun G; Pan P
    Sci Rep; 2024 Jun; 14(1):13367. PubMed ID: 38862693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential gene expression and network analysis in head and neck squamous cell carcinoma.
    Habib I; Anjum F; Mohammad T; Sulaimani MN; Shafie A; Almehmadi M; Yadav DK; Sohal SS; Hassan MI
    Mol Cell Biochem; 2022 May; 477(5):1361-1370. PubMed ID: 35142951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.
    Li J; Xiao W; Wei W; Wu M; Xiong K; Lyu J; Li Y
    Mol Immunol; 2023 Jun; 158():79-90. PubMed ID: 37172353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.